Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise Koch

Showing results (1-10 of 34) with videos related to

Pageof 4
Sort By:
Frontiers in Pharmacology|September 29, 2022
Drug repurposing candidates to treat core symptoms in autism spectrum disorderElise Koch, Ditte Demontis
Pharmacoepidemiology and Drug Safety|November 10, 2022
Longitudinal effects of using and discontinuing central nervous system medications on cognitive functioningElise Koch, Kristina Johnell, Karolina Kauppi
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 13, 2022
Candidates for drug repurposing to address the cognitive symptoms in schizophreniaElise Koch, Karolina Kauppi, Chi-Hua Chen
Genes|March 25, 2022
Polygenic Risk for Schizophrenia Has Sex-Specific Effects on Brain Activity during Memory Processing in Healthy IndividualsElise Koch, Lars Nyberg, Anders Lundquist, et al.
Scientific Reports|May 24, 2023
APOE ɛ4, but not polygenic Alzheimer's disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individualsSofia Håglin, Elise Koch, Fernanda Schäfer Hackenhaar, et al.
Schizophrenia Research|June 18, 2020
Interactome overlap between schizophrenia and cognitionElise Koch, Brin Rosenthal, Anders Lundquist, et al.
Translational Psychiatry|October 12, 2021
Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individualsElise Koch, Lars Nyberg, Anders Lundquist, et al.
Neurobiology of Aging|March 25, 2023
Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in agingAdil Supiyev, Robert Karlsson, Yunzhang Wang, et al.
Human Genomics|September 28, 2024
Genome-wide association analysis of treatment resistant schizophrenia for variant discovery and polygenic assessmentHasan Çağın Lenk, Elise Koch, Kevin S O'Connell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 18, 2025
Polygenic overlap with granulocyte counts identifies novel loci for clozapine metabolism and clozapine-induced agranulocytosisElise Koch, Alexey A Shadrin, Nadine Parker, et al.
Pageof 4

Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Frontiers in Pharmacology|September 29, 2022
Drug repurposing candidates to treat core symptoms in autism spectrum disorderElise Koch, Ditte Demontis
Pharmacoepidemiology and Drug Safety|November 10, 2022
Longitudinal effects of using and discontinuing central nervous system medications on cognitive functioningElise Koch, Kristina Johnell, Karolina Kauppi
Progress in Neuro-Psychopharmacology & Biological Psychiatry|September 13, 2022
Candidates for drug repurposing to address the cognitive symptoms in schizophreniaElise Koch, Karolina Kauppi, Chi-Hua Chen
Genes|March 25, 2022
Polygenic Risk for Schizophrenia Has Sex-Specific Effects on Brain Activity during Memory Processing in Healthy IndividualsElise Koch, Lars Nyberg, Anders Lundquist, et al.
Scientific Reports|May 24, 2023
APOE ɛ4, but not polygenic Alzheimer's disease risk, is related to longitudinal decrease in hippocampal brain activity in non-demented individualsSofia Håglin, Elise Koch, Fernanda Schäfer Hackenhaar, et al.
Schizophrenia Research|June 18, 2020
Interactome overlap between schizophrenia and cognitionElise Koch, Brin Rosenthal, Anders Lundquist, et al.
Translational Psychiatry|October 12, 2021
Sex-specific effects of polygenic risk for schizophrenia on lifespan cognitive functioning in healthy individualsElise Koch, Lars Nyberg, Anders Lundquist, et al.
Neurobiology of Aging|March 25, 2023
Independent role of Alzheimer's disease genetics and C-reactive protein on cognitive ability in agingAdil Supiyev, Robert Karlsson, Yunzhang Wang, et al.
Human Genomics|September 28, 2024
Genome-wide association analysis of treatment resistant schizophrenia for variant discovery and polygenic assessmentHasan Çağın Lenk, Elise Koch, Kevin S O'Connell, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|January 18, 2025
Polygenic overlap with granulocyte counts identifies novel loci for clozapine metabolism and clozapine-induced agranulocytosisElise Koch, Alexey A Shadrin, Nadine Parker, et al.
Pageof 4